Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Presentation LAA 2017

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Presenter: Apostolos Tzikas

July 22, 2017

Presentation LAA 2017

Watchman: Complication Frequency, Prevention, Recognition, and Management

Presenter: Jacqueline Saw

July 21, 2017

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

Presenter: Brian K. Whisenant

February 03, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Presentation LAA 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presenter: Maurice Buchbinder

July 19, 2014

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Presenter: Apostolos Tzikas

October 27, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

Presentation TCT 2013

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

Presenter: Bryan Yan, Chow Innes, Yat Yin Lam, Vivian Lee, Cheuk Man Yu

January 31, 2013

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

Advertisement

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Watchman: Complication Frequency, Prevention, Recognition, and Management

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Rationale and Identifying the Patient Who Might Benefit

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

LAA Occlusion for Stroke Prevention in A-Fib

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Can LAA Closure Become the New Standard for Stroke Prevention?

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Multicenter Experience with the ACP for Stroke Prevention in Atrial Fibrillation

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Cost-effectiveness Of Transcatheter Left Atrial Appendage Occlusion Compared With 5 Alternative Anticoagulation Strategies For Stroke Prevention In Atrial Fibrillation: A Markov...

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content